The effect of tumor size and location on efficacy and safety of US- and CT- guided percutaneous microwave ablation in renal cell carcinomas
- 7 March 2019
- journal article
- research article
- Published by Springer Nature in Abdominal Radiology
- Vol. 44 (6) , 2308-2315
Abstract
Purpose To evaluate the effect of size and central location of the tumor on safety and efficacy of percutaneous CEUS- and CT-guided MWA in biopsy-proven renal cell carcinomas (RCCs). Materials and methods In this IRB-approved retrospective study, 69 biopsy-proven renal tumors in 56 patients, who underwent MWA in our institution from January 2013 to March 2017, were evaluated. Data collection included demographics, tumor characteristics, procedural protocols, and follow-up visits within 6 months post procedure. Primary outcomes were assessed by technical success (TS), local tumor progression (LTP), and complications. The Kaplan–Meier analysis was used for survival rate. Results Overall technical success was achieved for all 69 lesions (92.8% primary TS, 100% overall). Median nephrometry score was 8 (4–11) and median tumor size was 2.5 cm (0.8–7). Five lesions which required second ablation had significantly higher median tumor size 4 cm (P = 0.039) with the same nephrometry score. Renal function remained stable with no significant change in eGFR before or after ablation. The LTP rate was 5.8%. The most recurrent tumors were clear cell (50%) followed by papillary tumors (25%). The complication rate was 5.8% with minor complications (hematoma and pain) and no major issues. There was no significant association between nephrometry score and technical success, recurrence, or complication rates. Overall and tumor-specific survival rates were 96.7% and 100% at 11.9 months. Conclusions Image-guided MWA appears to be a safe and effective treatment regardless of nephrometry score and tumor location with high technical success, low recurrence, and complication rates.Keywords
This publication has 23 references indexed in Scilit:
- Thermal ablation of the small renal mass: Case selection using the R.E.N.A.L.-Nephrometry ScoreUrologic Oncology: Seminars and Original Investigations, 2013
- Cryoablation versus Radiofrequency Ablation for Renal Tumor Ablation: Time to Reassess?Journal of Vascular and Interventional Radiology, 2013
- Usefulness of R.E.N.A.L. Nephrometry Scoring System for Predicting Outcomes and Complications of Percutaneous Ablation of 751 Renal TumorsJournal of Urology, 2013
- Long-Term Outcomes of Renal Tumor Radio Frequency Ablation Stratified by Tumor Diameter: Size MattersJournal of Urology, 2012
- Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta‐analysis of case series studiesBJU International, 2012
- Comparison of Microwave Ablation and Multipolar Radiofrequency Ablation In Vivo Using Two Internally Cooled ProbesAmerican Journal of Roentgenology, 2012
- Utility of the R.E.N.A.L. Nephrometry Scoring System in Objectifying Treatment Decision-making of the Enhancing Renal MassUrology, 2011
- Initial Experience with Retroperitoneoscopic Microwave Ablation of Clinical T 1a Renal TumorsJournal of Endourology, 2010
- The R.E.N.A.L. Nephrometry Score: A Comprehensive Standardized System for Quantitating Renal Tumor Size, Location and DepthJournal of Urology, 2009
- Classification of Surgical ComplicationsAnnals of Surgery, 2004